Investor Days 2026

25 – 26 Nov 2026 | Milan, Italy

Register
Register
Register

ClinMark Therapeutics

Start-up

www.clinmarktherapeutics.comMilano, Italy
5 profile visits

About

Digital technologies

AIDigital technologies

Health

BiotechMedtechPharma

Additional Information

Business Project Description

Poor patient stratification and limited predictive biomarkers reduce treatment effectiveness. ClinMark Therapeutics is developing an AI-driven platform that predicts therapeutic response by matching patient profiles with real-world multimodal response signatures. Target customers include pharma, CROs, and research centers. Funding and coaching will support MVP development, dataset harmonization, AI infrastructure, and key hires.

Product/Technology Development Stage

Proof of concept

Organization description

ClinMark Therapeutics is an early-stage precision medicine startup founded by a translational oncology researcher and supported by clinical and scientific collaborators. The team combines expertise in oncology, hepatology, pathology, biomarker discovery, clinical trials, and biostatistics, with access to longitudinal patient cohorts for platform development and validation. Its mission is to advance precision medicine through therapeutic response prediction.

Team size

3-5

Team Background

BusinessScientific Research

IPR Status

No IPR applied

If other, describe it

None

If other, describe it

None

Annual turnover (€)

no turnover

Would you like to apply for the pitching session and EEN award? (only for participants based in Lombardy)

Yes

Establishment year

2026

Type of funding raised

None

I participated in the Start Cup initiative of Lombardy Region

Yes

I received the Seal of Excellence for an EIC Accelerator project proposal

No

Representatives

ClinMark Therapeutics